Oncoinvent ASA (KLDVK) — Capital Reinvestment Ratio
Oncoinvent ASA (KLDVK) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Nkr3.64 Million) in capital expenditures (Nkr2.12 Million). See Oncoinvent ASA (KLDVK) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncoinvent ASA Capital Reinvestment Ratio (2021–2022)
This chart tracks Oncoinvent ASA's Capital Reinvestment Ratio across 2 annual periods. Check Oncoinvent ASA (KLDVK) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oncoinvent ASA (2021–2022)
Year-by-year Capital Reinvestment Ratio for Oncoinvent ASA from 2021 to 2022. For live market cap and broader valuation context, see Oncoinvent ASA (KLDVK) total market value.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 32.49x | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr130.66K | Nkr30.88 Million | — |